Avidity Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 16.51 M | $480.10 M | -2.01% | 13.38% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 11.04 M | $321.13 M | 3.84% | 8.95% |
BLACKROCK, INC. | 02/07/2025 | 9.93 M | $288.83 M | 2.11% | 8.05% |
VANGUARD GROUP INC | 02/11/2025 | 9.43 M | $274.28 M | 2.22% | 7.64% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 8.11 M | $235.73 M | 15.29% | 6.57% |
RTW INVESTMENTS, LP | 02/14/2025 | 7.93 M | $230.69 M | -2.46% | 6.43% |
AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 7.50 M | $218.10 M | 9.09% | 6.08% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 7.05 M | $205.13 M | 44.05% | 5.72% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 6.30 M | $183.22 M | 0.00% | 5.11% |
STATE STREET CORP | 02/14/2025 | 4.60 M | $133.83 M | -2.21% | 3.73% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.81 M | $82.83 M | 8.59% | 2.28% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.75 M | $80.03 M | -10.63% | 2.23% |
CASDIN CAPITAL, LLC | 02/14/2025 | 2.05 M | $59.47 M | -1.91% | 1.66% |
02/14/2025 | 1.73 M | $50.23 M | 100.00% | 1.40% | |
POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 1.27 M | $36.99 M | -17.52% | 1.03% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.23 M | $35.71 M | 40.84% | 1.00% |
MORGAN STANLEY | 02/14/2025 | 1.21 M | $35.30 M | 98.58% | 0.98% |
SIREN, L.L.C. | 02/14/2025 | 1.13 M | $32.78 M | -21.76% | 0.91% |
ORBIMED ADVISORS LLC | 02/14/2025 | 1.11 M | $32.36 M | 6.52% | 0.90% |
NORTHERN TRUST CORP | 02/14/2025 | 1.08 M | $31.39 M | 11.15% | 0.87% |
CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 1.05 M | $30.53 M | 0.00% | 0.85% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.03 M | $29.92 M | 3.91% | 0.83% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/12/2025 | 1.02 M | $29.52 M | -23.62% | 0.82% |
WOODLINE PARTNERS LP | 02/14/2025 | 865,820 | $25.18 M | 27.67% | 0.70% |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 799,028 | $23.24 M | 1.60% | 0.65% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 763,055 | $22.19 M | -12.77% | 0.62% |
NORGES BANK | 02/12/2025 | 724,787 | $21.08 M | 100.00% | 0.59% |
BIOIMPACT CAPITAL LLC | 02/14/2025 | 702,981 | $20.44 M | 2.03% | 0.57% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 674,256 | $19.61 M | 0.32% | 0.55% |
D. E. SHAW & CO., INC. | 02/14/2025 | 558,969 | $16.25 M | -49.58% | 0.45% |
ECOR1 CAPITAL, LLC | 02/14/2025 | 557,576 | $16.21 M | -26.40% | 0.45% |
SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 543,651 | $15.81 M | 14.32% | 0.44% |
JPMORGAN CHASE & CO | 02/12/2025 | 450,144 | $13.09 M | -3.63% | 0.36% |
MAN GROUP PLC | 02/14/2025 | 422,421 | $12.28 M | -53.59% | 0.34% |
ALETHEA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 420,871 | $12.24 M | -1.54% | 0.34% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 415,172 | $12.07 M | -4.55% | 0.34% |
CITADEL ADVISORS LLC | 02/14/2025 | 411,675 | $11.97 M | 100.00% | 0.33% |
FIERA CAPITAL CORP | 01/29/2025 | 401,179 | $11.67 M | -6.96% | 0.33% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 400,000 | $11.63 M | 100.00% | 0.32% |
FINEPOINT CAPITAL LP | 02/13/2025 | 391,300 | $11.38 M | 100.00% | 0.32% |
EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 375,924 | $10.93 M | 0.00% | 0.30% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 363,017 | $10.56 M | 19.52% | 0.29% |
CANDRIAM S.C.A. | 02/07/2025 | 360,710 | $10.49 M | 11.54% | 0.29% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 352,498 | $10.25 M | -66.70% | 0.29% |
VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 346,186 | $10.07 M | 1.08% | 0.28% |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 332,389 | $9.67 M | -4.72% | 0.27% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 264,305 | $7.69 M | 2.66% | 0.21% |
BARCLAYS PLC | 02/13/2025 | 250,011 | $7.27 M | -2.22% | 0.20% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 223,759 | $6.51 M | 100.00% | 0.18% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 217,855 | $6.34 M | 0.38% | 0.18% |
Avidity Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 292 institutional investors and hedge funds held shares of Avidity Biosciences, Inc.. The most heavily invested institutionals were:
FMR LLC: 16.51 M
PRICE T ROWE ASSOCIATES INC /MD/: 11.04 M
BlackRock, Inc.: 9.93 M
VANGUARD GROUP INC: 9.43 M
WELLINGTON MANAGEMENT GROUP LLP: 8.11 M
RTW INVESTMENTS, LP: 7.93 M
103.49% of Avidity Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 136.82 M shares in the last 24 months. This purchase volume represents approximately $3.39 B in transactions.